Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60


Employment Outcomes, Financial Burden, Anxiety, and Depression Among Caregivers of African American Cancer Survivors.

Hastert TA, Ruterbusch JJ, Nair M, Noor MI, Beebe-Dimmer JL, Schwartz K, Baird TE, Harper FWK, Thompson H, Schwartz AG.

J Oncol Pract. 2019 Sep 7:JOP1900410. doi: 10.1200/JOP.19.00410. [Epub ahead of print]


Race, financial hardship, and limiting care due to cost in a diverse cohort of cancer survivors.

Hastert TA, Banegas MP, Hamel LM, Reed AR, Baird T, Beebe-Dimmer JL, Schwartz AG.

J Cancer Surviv. 2019 Jun;13(3):429-437. doi: 10.1007/s11764-019-00764-y. Epub 2019 May 29.


Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.

Beebe-Dimmer JL, Ruterbusch JJ, Cooney KA, Bolton A, Schwartz K, Schwartz AG, Heath E.

Cancer Med. 2019 Jun;8(6):3325-3335. doi: 10.1002/cam4.2092. Epub 2019 May 15.


Mitochondrial alterations may underlie race-specific differences in cancer risk and outcome.

Beebe-Dimmer JL, Cooney KA.

J Clin Invest. 2019 May 6;129(6):2187-2188. doi: 10.1172/JCI128707. eCollection 2019 May 6.


Financial Hardship and Quality of Life among African American and White Cancer Survivors: The Role of Limiting Care Due to Cost.

Hastert TA, Kyko JM, Reed AR, Harper FWK, Beebe-Dimmer JL, Baird TE, Schwartz AG.

Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1202-1211. doi: 10.1158/1055-9965.EPI-18-1336. Epub 2019 May 6.


The Epidemiology of Cancer Among Homeless Adults in Metropolitan Detroit.

Holowatyj AN, Heath EI, Pappas LM, Ruterbusch JJ, Gorski DH, Triest JA, Park HK, Beebe-Dimmer JL, Schwartz AG, Cote ML, Schwartz KL.

JNCI Cancer Spectr. 2019 Mar;3(1):pkz006. doi: 10.1093/jncics/pkz006. Epub 2019 Mar 25.


Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.

Van Dyke AL, Shiels MS, Jones GS, Pfeiffer RM, Petrick JL, Beebe-Dimmer JL, Koshiol J.

Cancer. 2019 May 1;125(9):1489-1498. doi: 10.1002/cncr.31942. Epub 2019 Jan 15.


The Detroit Research on Cancer Survivors (ROCS) Pilot Study: A Focus on Outcomes after Cancer in a Racially Diverse Patient Population.

Beebe-Dimmer JL, Albrecht TL, Baird TE, Ruterbusch JJ, Hastert T, Harper FWK, Simon MS, Abrams J, Schwartz KL, Schwartz AG.

Cancer Epidemiol Biomarkers Prev. 2019 Apr;28(4):666-674. doi: 10.1158/1055-9965.EPI-18-0123. Epub 2018 Nov 27.


The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancer.

Dyson G, Farran B, Bolton S, Craig DB, Dombkowski A, Beebe-Dimmer JL, Powell IJ, Podgorski I, Heilbrun LK, Bock CH.

Am J Cancer Res. 2018 Oct 1;8(10):2088-2095. eCollection 2018.


Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population.

Greenwald MK, Ruterbusch JJ, Beebe-Dimmer JL, Simon MS, Albrecht TL, Schwartz AG.

Cancer. 2019 Jan 15;125(2):269-277. doi: 10.1002/cncr.31798. Epub 2018 Nov 2.


Real-world testing and treatment patterns in chronic lymphocytic leukemia: A SEER patterns of care analysis.

Seymour EK, Ruterbusch JJ, Beebe-Dimmer JL, Schiffer CA.

Cancer. 2019 Jan 1;125(1):135-143. doi: 10.1002/cncr.31738. Epub 2018 Oct 21.


Correction to: Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database.

Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC, Gillezeau C, Fryzek J, Schultz NM, Flanders SC, Barlev A, Heath E, Quek RGW.

Adv Ther. 2018 Sep;35(9):1452. doi: 10.1007/s12325-018-0767-0.


Finding a Needle in the Haystack: The Search for Germline Variants Associated with Prostate Cancer Clinical Outcomes.

Cooney KA, Beebe-Dimmer JL.

Eur Urol. 2018 Dec;74(6):720-721. doi: 10.1016/j.eururo.2018.07.001. Epub 2018 Jul 17. No abstract available.


Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database.

Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC, Gillezeau C, Fryzek J, Schultz NM, Flanders SC, Barlev A, Heath E, Quek RGW.

Adv Ther. 2018 Sep;35(9):1438-1451. doi: 10.1007/s12325-018-0738-5. Epub 2018 Jun 26. Erratum in: Adv Ther. 2018 Aug 16;:.


Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer.

Campbell DH, Lund ME, Nocon AL, Cozzi PJ, Frydenberg M, De Souza P, Schiller B, Beebe-Dimmer JL, Ruterbusch JJ, Walsh BJ.

PLoS One. 2018 Apr 19;13(4):e0196017. doi: 10.1371/journal.pone.0196017. eCollection 2018.


Comparing Treatment Strategies for Stage I Small-cell lung Cancer.

Paximadis P, Beebe-Dimmer JL, George J, Schwartz AG, Wozniak A, Gadgeel S.

Clin Lung Cancer. 2018 Sep;19(5):e559-e565. doi: 10.1016/j.cllc.2018.03.017. Epub 2018 Mar 23.


Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.

Schwartz KL, Simon MS, Bylsma LC, Ruterbusch JJ, Beebe-Dimmer JL, Schultz NM, Flanders SC, Barlev A, Fryzek JP, Quek RGW.

Cancer. 2018 May 15;124(10):2104-2114. doi: 10.1002/cncr.31299. Epub 2018 Mar 5.


A study of circulating microRNAs identifies a new potential biomarker panel to distinguish aggressive prostate cancer.

Farran B, Dyson G, Craig D, Dombkowski A, Beebe-Dimmer JL, Powell IJ, Podgorski I, Heilbrun L, Bolton S, Bock CH.

Carcinogenesis. 2018 Apr 5;39(4):556-561. doi: 10.1093/carcin/bgy025.


Rare germline mutations in African American men diagnosed with early-onset prostate cancer.

Beebe-Dimmer JL, Zuhlke KA, Johnson AM, Liesman D, Cooney KA.

Prostate. 2018 Apr;78(5):321-326. doi: 10.1002/pros.23464. Epub 2018 Jan 21.


Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative.

Simon MS, Beebe-Dimmer JL, Hastert TA, Manson JE, Cespedes Feliciano EM, Neuhouser ML, Ho GYF, Freudenheim JL, Strickler H, Ruterbusch J, Barac A, Chlebowski R, Caan B.

Cancer. 2018 Apr 15;124(8):1798-1807. doi: 10.1002/cncr.31230. Epub 2018 Jan 16.


Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women's health initiative.

Beebe-Dimmer JL, Yee C, Paskett E, Schwartz AG, Lane D, Palmer NRA, Bock CH, Nassir R, Simon MS.

BMC Cancer. 2017 Dec 13;17(1):848. doi: 10.1186/s12885-017-3873-5.


The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study.

Bock CH, Jay AM, Dyson G, Beebe-Dimmer JL, Cote ML, Hou L, Howard BV, Desai P, Purrington K, Prentice R, Simon MS.

Breast Cancer Res Treat. 2018 Feb;167(3):741-749. doi: 10.1007/s10549-017-4521-0. Epub 2017 Oct 24.


Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data.

Thakur MK, Ruterbusch JJ, Schwartz AG, Gadgeel SM, Beebe-Dimmer JL, Wozniak AJ.

J Thorac Oncol. 2018 Jan;13(1):46-53. doi: 10.1016/j.jtho.2017.09.1964. Epub 2017 Oct 5.


Familial prostate cancer.

Giri VN, Beebe-Dimmer JL.

Semin Oncol. 2016 Oct;43(5):560-565. doi: 10.1053/j.seminoncol.2016.08.001. Epub 2016 Aug 18.


Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival.

Beebe-Dimmer JL, Fryzek JP, Yee CL, Dalvi TB, Garabrant DH, Schwartz AG, Gadgeel S.

Clin Epidemiol. 2016 Oct 26;8:743-750. eCollection 2016.


HOXB13 mutations and prostate cancer risk.

Cooney KA, Beebe-Dimmer JL.

BJU Int. 2016 Oct;118(4):496-7. doi: 10.1111/bju.13477. No abstract available.


The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.

Beebe-Dimmer JL, Hathcock M, Yee C, Okoth LA, Ewing CM, Isaacs WB, Cooney KA, Thibodeau SN.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1366-72. doi: 10.1158/1055-9965.EPI-15-0247. Epub 2015 Jun 24.


Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study.

Beebe-Dimmer JL, Yee C, Cote ML, Petrucelli N, Palmer N, Bock C, Lane D, Agalliu I, Stefanick ML, Simon MS.

Cancer. 2015 Apr 15;121(8):1265-72. doi: 10.1002/cncr.29075. Epub 2015 Mar 9.


Antioxidant micronutrients and the risk of renal cell carcinoma in the Women's Health Initiative cohort.

Ho WJ, Simon MS, Yildiz VO, Shikany JM, Kato I, Beebe-Dimmer JL, Cetnar JP, Bock CH.

Cancer. 2015 Feb 15;121(4):580-8. doi: 10.1002/cncr.29091. Epub 2014 Oct 9.


Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study.

Davis EJ, Beebe-Dimmer JL, Yee CL, Cooney KA.

Cancer. 2014 Sep 1;120(17):2735-41. doi: 10.1002/cncr.28769. Epub 2014 May 19.


Gene-environment interactions between JAZF1 and occupational and household lead exposure in prostate cancer among African American men.

Neslund-Dudas C, Levin AM, Beebe-Dimmer JL, Bock CH, Nock NL, Rundle A, Jankowski M, Krajenta R, Dou QP, Mitra B, Tang D, Rebbeck TR, Rybicki BA.

Cancer Causes Control. 2014 Jul;25(7):869-79. doi: 10.1007/s10552-014-0387-1. Epub 2014 May 7.


Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.

Beebe-Dimmer JL, Isaacs WB, Zuhlke KA, Yee C, Walsh PC, Isaacs SD, Johnson AM, Ewing CE, Humphreys EB, Chowdhury WH, Montie JE, Cooney KA.

BJU Int. 2014 May;113(5):830-5. doi: 10.1111/bju.12522. Epub 2014 Mar 5.


Current perspective on the global and United States cancer burden attributable to lifestyle and environmental risk factors.

Schottenfeld D, Beebe-Dimmer JL, Buffler PA, Omenn GS.

Annu Rev Public Health. 2013;34:97-117. doi: 10.1146/annurev-publhealth-031912-114350. Review.


Androgen deprivation therapy: further confirmation of known harms.

Beebe-Dimmer JL, Freedland SJ.

BJU Int. 2013 May;111(5):690-1. doi: 10.1111/j.1464-410X.2013.11797.x. Epub 2013 Feb 18. No abstract available.


Body mass index and renal cell cancer: the influence of race and sex.

Beebe-Dimmer JL, Colt JS, Ruterbusch JJ, Keele GR, Purdue MP, Wacholder S, Graubard BI, Davis F, Chow WH, Schwartz KL.

Epidemiology. 2012 Nov;23(6):821-8. doi: 10.1097/EDE.0b013e31826b7fe9.


Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy.

Asmar R, Beebe-Dimmer JL, Korgavkar K, Keele GR, Cooney KA.

Prostate Cancer Prostatic Dis. 2013 Mar;16(1):62-6. doi: 10.1038/pcan.2012.32. Epub 2012 Aug 21.


Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study.

Beebe-Dimmer JL, Iyer PT, Nriagu JO, Keele GR, Mehta S, Meliker JR, Lange EM, Schwartz AG, Zuhlke KA, Schottenfeld D, Cooney KA.

Environ Health. 2012 Jun 29;11:43. doi: 10.1186/1476-069X-11-43.


Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States.

Beebe-Dimmer JL, Cetin K, Shahinian V, Morgenstern H, Yee C, Schwartz KL, Acquavella J.

Pharmacoepidemiol Drug Saf. 2012 Jan;21(1):70-8. doi: 10.1002/pds.2258. Epub 2011 Nov 24.


The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy.

Post JM, Beebe-Dimmer JL, Morgenstern H, Neslund-Dudas C, Bock CH, Nock N, Rundle A, Jankowski M, Rybicki BA.

Prostate Cancer. 2011;2011:245642. doi: 10.1155/2011/245642. Epub 2011 Sep 25.


Prevalence and correlates of vitamin and supplement usage among men with a family history of prostate cancer.

Bauer CM, Ishak MB, Johnson EK, Beebe-Dimmer JL, Cooney KA.

Integr Cancer Ther. 2012 Jun;11(2):83-9. doi: 10.1177/1534735411413262. Epub 2011 Aug 5.


Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans.

Beebe-Dimmer JL, Zuhlke KA, Ray AM, Lange EM, Cooney KA.

Prostate Cancer Prostatic Dis. 2010 Dec;13(4):362-8. doi: 10.1038/pcan.2010.27. Epub 2010 Aug 10.


The Duffy Antigen/Receptor for Chemokines (DARC) and prostate-cancer risk among Jamaican men.

Elson JK, Beebe-Dimmer JL, Morgenstern H, Chilkuri M, Blanchard J, Lentsch AB.

J Immigr Minor Health. 2011 Feb;13(1):36-41. doi: 10.1007/s10903-010-9330-z.


Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program.

Cetin K, Beebe-Dimmer JL, Fryzek JP, Markus R, Carducci MA.

Urology. 2010 Jun;75(6):1396-404. doi: 10.1016/j.urology.2009.07.1360. Epub 2009 Dec 6.


Racial differences in risk of prostate cancer associated with metabolic syndrome.

Beebe-Dimmer JL, Nock NL, Neslund-Dudas C, Rundle A, Bock CH, Tang D, Jankowski M, Rybicki BA.

Urology. 2009 Jul;74(1):185-90. doi: 10.1016/j.urology.2009.03.013. Epub 2009 May 9.


The epidemiology of malignant giant cell tumors of bone: an analysis of data from the Surveillance, Epidemiology and End Results Program (1975-2004).

Beebe-Dimmer JL, Cetin K, Fryzek JP, Schuetze SM, Schwartz K.

Rare Tumors. 2009 Dec 28;1(2):e52. doi: 10.4081/rt.2009.e52.


The epidemiology and pathogenesis of neoplasia in the small intestine.

Schottenfeld D, Beebe-Dimmer JL, Vigneau FD.

Ann Epidemiol. 2009 Jan;19(1):58-69. doi: 10.1016/j.annepidem.2008.10.004. Review.


Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23.

Lange EM, Beebe-Dimmer JL, Ray AM, Zuhlke KA, Ellis J, Wang Y, Walters S, Cooney KA.

Prostate. 2009 Mar 1;69(4):385-91. doi: 10.1002/pros.20891.


Chromosome 8q24 markers: risk of early-onset and familial prostate cancer.

Beebe-Dimmer JL, Levin AM, Ray AM, Zuhlke KA, Machiela MJ, Halstead-Nussloch BA, Johnson GR, Cooney KA, Douglas JA.

Int J Cancer. 2008 Jun 15;122(12):2876-9. doi: 10.1002/ijc.23471.


Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study.

Beebe-Dimmer JL, Faerber GJ, Morgenstern H, Werny D, Wojno K, Halstead-Nussloch B, Cooney KA.

Urology. 2008 Apr;71(4):554-60. doi: 10.1016/j.urology.2007.11.049. Epub 2008 Mar 4. Review.


Features of the metabolic syndrome and prostate cancer in African-American men.

Beebe-Dimmer JL, Dunn RL, Sarma AV, Montie JE, Cooney KA.

Cancer. 2007 Mar 1;109(5):875-81.

Supplemental Content

Loading ...
Support Center